Literature DB >> 27278635

Second denervation in a patient with resistant hypertension.

Jose Carlos Prado1, Dayan Salado2, Luis Miguel Ruilope2, Julian Segura2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27278635     DOI： 10.1007/s00392-016-0997-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  25 in total

Review 1.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

Review 2.  The biophysics of renal sympathetic denervation using radiofrequency energy.

Authors:  Hitesh C Patel; Paramdeep S Dhillon; Felix Mahfoud; Alistair C Lindsay; Carl Hayward; Sabine Ernst; Alexander R Lyon; Stuart D Rosen; Carlo di Mario
Journal:  Clin Res Cardiol       Date:  2014-05       Impact factor: 5.460

3.  Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach.

Authors:  Marco R Schroeter; Michael Koziolek
Journal:  Clin Res Cardiol       Date:  2013-11-19       Impact factor: 5.460

4.  Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

Authors:  George L Bakris; Raymond R Townsend; Minglei Liu; Sidney A Cohen; Ralph D'Agostino; John M Flack; David E Kandzari; Barry T Katzen; Martin B Leon; Laura Mauri; Manuela Negoita; William W O'Neill; Suzanne Oparil; Krishna Rocha-Singh; Deepak L Bhatt
Journal:  J Am Coll Cardiol       Date:  2014-05-20       Impact factor: 24.094

5.  Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia.

Authors:  Sebastian Hilbert; Cathleen Rogge; Polykarpos Papageorgiou; Gerhard Hindricks; Andreas Bollmann
Journal:  Clin Res Cardiol       Date:  2014-11-11       Impact factor: 5.460

6.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

7.  Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.

Authors:  Janine Pöss; Sebastian Ewen; Roland E Schmieder; Sonja Muhler; Oliver Vonend; Christian Ott; Dominik Linz; Jürgen Geisel; Lars C Rump; Markus Schlaich; Michael Böhm; Felix Mahfoud
Journal:  Clin Res Cardiol       Date:  2015-02-26       Impact factor: 5.460

8.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

9.  Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.

Authors:  Sebastian Ewen; Markus R Meyer; Bodo Cremers; Ulrich Laufs; Andreas G Helfer; Dominik Linz; Ingrid Kindermann; Christian Ukena; Michel Burnier; Stefan Wagenpfeil; Hans H Maurer; Michael Böhm; Felix Mahfoud
Journal:  Clin Res Cardiol       Date:  2015-08-26       Impact factor: 5.460

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  1 in total

1.  Flow-mediated dilation, nitroglycerin-mediated dilation and their ratio predict successful renal denervation in mild resistant hypertension.

Authors:  Martin Steinmetz; Dominik Nelles; Jutta Weisser-Thomas; Christian Schaefer; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2018-04-11       Impact factor: 5.460
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.